Home >
News >
#ESHCML2022 PROGRAM HIGHLIGHTS: 4 SPECIAL LECTURES
#ESHCML2022 PROGRAM HIGHLIGHTS: 4 SPECIAL LECTURES
July 13, 2022
24th ANNUAL JOHN GOLDMAN CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
BIOLOGY AND THERAPY
Save the date: October 21-23, 2022
Mandelieu-La Napoule, France - #ESHCML2022
Co-organizers: R. Bathia, T. Brümmendorf, M. Copland, M. Deininger, O. Hantschel,
F-X. Mahon, D. Perrotti, J. Radich, D. Réa
Advisory Committee: J. Apperley, S. Branford, C. Gambacorti-Passerini, F. Guilhot,
R. Hehlmann, P. Laneuville, G. Saglio, C. Schiffer, S. Soverini, P. Valent, R. Van Etten
Some of the main highlights of the program are the
SPECIAL LECTURES:
DO NOT MISS THE OPPORTUNITY AND REGISTER FOR THE CONFERENCE
DEADLINE TO SUBMIT LATE BREAKING ABSTRACTS
FOR ORAL AND POSTER PRESENTATIONS:
JULY 30th, 2022 (23:59 CEST)
ONE MONTH LEFT
ABOUT THE CONFERENCE
Strong basic and clinical science:
Speakers at this meeting will present new, often unpublished data related to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) aspects of treatment including prediction and definition of responses, drugs used in combination, modern diagnostics and molecular monitoring, targeting residual stem cells, approaches to cure and treatment free remission.
The programme will include
- Special Lectures
- Keynote Lectures
- Oral Communications selected from Submitted Abstracts
- Workshops for Non-Clinical Scientists
- Mentored Poster Walks: Clinical and Biology
- Michele Baccarani Special Symposium (topic to be announced)
- The John Goldman Prize Ceremony and Lecture
- The Janet Rowley Prize Ceremony and Lecture
- The iCMLf Prize Ceremony and Lecture
- The ESH John Goldman International Research Award ceremony
and scientific presentation
MORE INFORMATION
LOCAL COVID-19 RULES
With the support of*:
Diamond Conference Partner
*******
*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.